ApexNano Medical

Electromagnetic Targeting of Nanomagnetic Particles

Health Tech & Life Sciences
Non Active, Jun 2019 ceased to operate

Company Overview

Snapshot

Founded in December 2016 by Dov V Shimon MD and Udi Katzenelson, ApexNano Medical operated with 1–10 employees. The company ceased operations in June 2019.

Business overview

ApexNano Medical was developing a medical technology that utilized superparamagnetic nanoparticles (SPIONs) made of iron oxide bound with tPA. The company's core technology involved a proprietary electromagnetic capture system designed to target these nanoformulations into clotted arteries, facilitating the release of tPA within the clot. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices, ApexNano Medical focused on cardiology and cardiovascular applications, serving global markets with a B2B business model.

Company Intelligence Q&A

What was ApexNano Medical's primary focus?
ApexNano Medical focused on developing a formulation of superparamagnetic nanoparticles (SPIONs) made of iron oxide bound with tPA, intended for targeted delivery within the body.
What technology did ApexNano Medical utilize?
The company's core technology involved a customized electromagnetic positioning workstation to target nanoformulations into clotted arteries, releasing tPA within the clot.
When was ApexNano Medical founded?
ApexNano Medical was founded in December 2016.
What was the operational status of ApexNano Medical?
ApexNano Medical ceased to operate in June 2019.
Who were the founders of ApexNano Medical?
The company was founded by Dov V Shimon MD and Udi Katzenelson.